Docetaxel/sunitinibLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1854卷 / 1期

关键词：

D O I：

10.1007/s40278-021-95468-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：137 / 137

相关论文

共 50 条

[41] Cisplatin/docetaxel/fluorouracilLack of efficacy: case report
[J]. Reactions Weekly, 2022, 1921 (1) : 91 - 91
[42] Docetaxel/nivolumabDermatomyositis and lack of efficacy: case report
[J]. Reactions Weekly, 2021, 1837 (1) : 221 - 221
[43] Cabazitaxel/docetaxel/enzalutamideLack of efficacy: case report
[J]. Reactions Weekly, 2023, 1976 (1) : 93 - 93
[44] Imatinib/SunitinibLack of efficacy
[J]. Reactions Weekly, 2024, 2015 (1) : 197 - 197
[45] Everolimus/Lanreotide/SunitinibLack of efficacy
[J]. Reactions Weekly, 2024, 2013 (1) : 195 - 195
[46] Docetaxel/poziotinibVarious toxicities and lack of efficacy: case report
[J]. Reactions Weekly, 2023, 1964 (1) : 173 - 173
[47] Docetaxel/gimeracil/oteracil/tegafurLack of efficacy: case report
[J]. Reactions Weekly, 2023, 1943 (1) : 284 - 284
[48] Cisplatin/docetaxel/fluorouracilAnaphylaxis and lack of efficacy: case report
[J]. Reactions Weekly, 2023, 1941 (1) : 143 - 143
[49] Docetaxel/pertuzumab/trastuzumabHypodermic necrosis following docetaxel extravasation and lack of efficacy: case report
[J]. Reactions Weekly, 2023, 1948 (1) : 170 - 170
[50] Cisplatin/docetaxel/gemcitabineVarious toxicities and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1926 (1) : 167 - 167

← 1 2 3 4 5 →